Johns Hopkins Singapore, a joint venture between the National Healthcare Group (NHG) and Johns Hopkins Medicine International, operates an inpatient and outpatient oncology program for both private and public patients in collaboration with Tan Tock Seng Hospital. We specialize in advanced treatments for a wide range of adult cancers and provide medical screenings and health checkup services.
Established in 2000 as a geographical alternative to The Johns Hopkins Hospital in the United States, we strive to extend the Johns Hopkins tradition of excellence in research, education and patient care in Southeast Asia.
In 2004, we became Singapore’s first private hospital to be accredited by the Joint Commission International, the world leader in health care standards. Our storied reputation of excellence stems from our state-of-the-art oncology facilities as well as our professional and compassionate team, who delivers only the highest standard of personalized care.
At Johns Hopkins Singapore, every patient can expect to receive world-class cancer treatment and meticulous care in a comfortable, healing atmosphere.
We are committed to providing our patients and their family members with the highest quality of inpatient and outpatient care. Some of our other services include outpatient consultations, chemotherapy, an intensive care unit, a laboratory, pharmacy services, internal medicine consultations, health screening programs, second opinions on more complex medical conditions and consultations with referring physicians for specialty services.
Combined with our active participation in diverse medical education and research, including collaborations with the Johns Hopkins University School of Medicine and local experts from the National University of Singapore and the National University Hospital, Johns Hopkins Singapore strives to work toward the discovery and development of new cutting-edge therapies and technologies to provide our patients with a better quality of life during and after treatment.